A top University of Minnesota official said $300 million should be considered the "upper limit" for what the U must pay to acquire its teaching hospital campus in Minneapolis and raised the question of whether it would have to pay anything at all.
The price could be less, said Myron Frans, the U's senior vice president for finance and operations, because the university believes the assets at the University of Minnesota Medical Center must be dedicated "in perpetuity" to the U's academic medicine mission.
Fairview Health Services owns the Minneapolis teaching hospital, which includes four somewhat distinct facilities that span the East Bank and West Bank campuses. The U wants control of the medical center because Fairview is planning to merge with South Dakota-based Sanford Health, a transaction that would shift control of the hospital campus to an out-of-state entity.
"The ability to transfer these [assets] outside of the University of Minnesota's academic health mission are limited — if not barred, potentially — which would obviously reduce or eliminate any actual cost in terms of the transfer cost. ... There's a question in our mind about any payment at all given the nature of the assets and their commitment to this public purpose," Frans said during a Friday meeting of the U's Board of Regents.
The comments came as the board voted to seek a total of $950 million in state funding related to the U hospital. The sum includes $300 million for the transfer plus staffing costs and another $650 million for initial operations.
Fairview said in a statement it is "eager to work with the University to identify an independent process to assess and determine a price that is agreeable to both parties."
"We have a duty to our patients to strive toward more affordability and greater value in the care we provide," the health system said. "This means, among other things, being good stewards of the assets we hold."
University of Minnesota Medical Center would be expected to cover its costs in the long run, Frans said, while also generating excess revenue for reinvestments.